Publications in collaboration with researchers from Jožef Stefan Institute (9)

2022

  1. UHPLC-HRMS data from non-targeted screening for biotransformation products of cytostatic drug imatinib

    Data in Brief

2021

  1. A novel workflow utilizing open-source software tools in the environmental fate studies: The example of imatinib biotransformation

    Science of the Total Environment, Vol. 797

2018

  1. Aerobic activated sludge transformation of vincristine and identification of the transformation products

    Science of the Total Environment, Vol. 610-611, pp. 892-904

2016

  1. Biodegradability of the anticancer drug etoposide and identification of the transformation products

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14706-14717

  2. First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14692-14704

  3. Toxicity of the mixture of selected antineoplastic drugs against aquatic primary producers

    Environmental Science and Pollution Research, Vol. 23, Núm. 15, pp. 14780-14790

2015

  1. Aerobic activated sludge transformation of methotrexate: Identification of biotransformation products

    Chemosphere, Vol. 119, pp. S42-S50

  2. Assessment of toxicity and genotoxicity of low doses of 5-fluorouracil in zebrafish (Danio rerio) two-generation study

    Water Research, Vol. 77, pp. 201-212

  3. In vitro Phase I and Phase II metabolism of α-pyrrolidinovalerophenone (α-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol

    Analytical and Bioanalytical Chemistry, Vol. 407, Núm. 19